This site uses cookies to provide services, collect traffic data, and personalize ads. You agree by using this site.
More info
en

Press releases


NEXTCLINICS adds the IVF Centers of Prof. Zech to portfolio and becomes one of the Europe’s 3 largest assisted reproductive technology providers 01.08.2018
Bregenz/Salzburg/Augsburg, 1 August 2018: On the heels of acquiring Italy’s GynePro Medical Group in June 2018, NEXTCLINICS is proud to announce it will take control of 100% of The IVF Centers Prof. ZECH (Zech IVF), one of Europe’s largest networks of in-vitro fertilization (IVF) clinics with offices in Bregenz, Salzburg, Cologne, Vaduz, Niederuzwil, Pilsen and Merano. In less than a year, NEXTCLINICS has expanded to be among Europe’s top 3 IVF providers with 14 clinics in its portfolio across the continent. NEXTCLINICS now has the perfect platform to invest into further European and global growth. Because of the enormous overlap of philosophy and principles between the two groups, Zech IVF’s founder Professor Dr. Herbert Zech has become shareholder in NEXTCLINICS. Further, Professor Zech will join the Medical Board in a leading position and will support the further international expansion of NEXTCLINICS. The transaction is part of the NEXTCLINICS plan to invest up to EUR 200 million in 2018. The valuation of the Zech IVF transaction will not be disclosed and is subject to Austrian anti-trust regulatory approval.
NEXTCLINICS continues growing, the group acquired prominent assisted reproduction clinics in Northern Italy  17.07.2018
Bologna/Augsburg, 17 July 2018: In late June 2018, NEXTCLINICS acquired 100% of GynePro, an Italian medical Group with in-vitro fertilization (IVF) clinics located in Bologna and Verona. With a 20 year history, GynePro is a highly experienced and renowned medical group active in the area of infertility management, assisted reproductive technology (ART), and prenatal diagnosis. GynePro’s founder, Professor Dr. Marco Filicori, will remain with the clinic as its Medical Director and will become a shareholder and investor in NEXTCLINICS. This transaction strengthens NEXTCLINICS’ position as a leading pan European provider of ART clinics and laboratories. This is NEXTCLINICS’ first major transaction in 2018, and follows a number of late 2017 investments in leading fertility centers and laboratories across Europe, valued at 80 million Euro. The valuation of the GynePro transaction will not be disclosed.
NL Holding announces it has secured Oaktree Capital Management as its partner for further expansion and the acquisition 15.02.2018
NL Holding announces it has secured Oaktree Capital Management, a major global investment group, as its partner for further expansion and the acquisition of healthcare facilities in Spain, Italy, and Switzerland.

NEXTCLINIC operates a network of modern and highly specialized healthcare facilities and offer care primarily in allergology, clinical immunology, pneumology, phtiseology as well as other related fields. We are a leading provider of assisted reproduction services (IVF), gynecology and obstetrics, and offer a diverse range of complimentary services. Our central fundamental guiding principle lies in a responsible and accountable approach to patients, one where information is shared, and where patients are encouraged to take an active role in their own wellbeing.

With presence on multiple European markets, NEXTCLINIC offers patients from around the world the opportunity to choose a preferred location and enjoy the benefits of unique destinations. Customers enjoy healthcare services, but also a wide range of complimentary services.

Project permeating across several disciplines, providing patients the ability to identify and integrate a whole new social group to gain many benefits. It creates opportunities for testing of your health and makes information about health and healthy lifestyle accessible.

The NEXTLIFE application change trends in patient communication with a physician. We allow quality and fast testing, where the patient can determine the time and method of examination. The NEXTLIFE magazine focuses on a healthy lifestyle.

NEXTLAB provides fast and accurate laboratory diagnostics on biological material for private GPs, outpatient specialists, hospitals, patients without a health insurance policy, and those who request laboratory services beyond standard testing.

NEXTLAB builds upon 20 years of experience with its own labs and sample collection centres, offering a wide range of lab tests based on the latest diagnostic methods, devices and technologies. Tests that are not carried out in our labs are forwarded to partner labs in compliance with a strict pre-analytical procedure.

You are leaving NEXTCLINICS website.

For more information about selected services, you will be redirected to %s.
Do you want to continue?

STAY ON THIS PAGE CONTINUE